Protective effect of short-term genistein supplementation on the early stage in diabetes-induced renal damage

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Kim, Min Ju ^a   Lim, Yunsook ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; C REACTIVE PROTEIN; CREATININE; CYCLOOXYGENASE 2; GENISTEIN; GLUCOSE; GLUTATHIONE PEROXIDASE; HEME OXYGENASE 1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEAR FACTOR; NUCLEAR RELATED FACTOR E2; PROTEIN KINASE C; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA II; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIOXIDANT; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIET; FEMALE; GLUCOSE BLOOD LEVEL; INFLAMMATION; KIDNEY INJURY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL; ANIMAL; BLOOD; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; INSTITUTE FOR CANCER RESEARCH MOUSE; KIDNEY; LIPID PEROXIDATION; METABOLISM; PATHOLOGY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS;

ANIMALS; ANTIOXIDANTS; BLOOD UREA NITROGEN; C-REACTIVE PROTEIN; CHEMOKINE CCL2; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FEMALE; GENISTEIN; KIDNEY; LIPID PEROXIDATION; MALONDIALDEHYDE; MICE; MICE, INBRED ICR; OXIDATIVE STRESS; PROTEIN KINASE C; PROTEIN KINASE C BETA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877940478     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/510212     Document Type: Article

References (93)

1. Setacci C., De Donato G., Setacci F., Chisci E., Diabetic patients: epidemiology and global impact. Journal of Cardiovascular Surgery 2009 50 3 263 273 2-s2.0-70349869245
2. Vallon V., Thomson S. C., Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annual Review of Physiology 2012 74 351 375
3. Maritim A. C., Sanders R. A., Watkins J. B. III, Diabetes, oxidative stress, and antioxidants: a review. Journal of Biochemical and Molecular Toxicology 2003 17 1 24 38 2-s2.0-0037253073 10.1002/jbt.10058 (Pubitemid 36410972)
4. Ponugoti B., Dong G., Graves D. T., Role of forkhead transcription factors in diabetes-induced oxidative stress. Experimental Diabetes Research 2012 2012 7 939751
5. Sanchez A. P., Sharma K., Transcription factors in the pathogenesis of diabetic nephropathy. Expert Reviews in Molecular Medicine 2009 11, article e13 2-s2.0-66149140626 10.1017/S1462399409001057
6. Schmid H., Boucherot A., Yasuda Y., Henger A., Brunner B., Eichinger F., Nitsche A., Kiss E., Bleich M., Gröne H. J., Nelson P. J., Schlöndorff D., Cohen C. D., Kretzler M., Modular activation of nuclear factor- B transcriptional programs in human diabetic nephropathy. Diabetes 2006 55 11 2993 3003 2-s2.0-33845526226 10.2337/db06-0477 (Pubitemid 44923635)
7. Valen G., Yan Z. Q., Hansson G. K., Nuclear factor kappa-B and the heart. Journal of the American College of Cardiology 2001 38 2 307 314 2-s2.0-0034908292 10.1016/S0735-1097(01)01377-8 (Pubitemid 32721754)
8. Pedruzzi L. M., Stockler-Pinto M. B., Leite M. Jr., Mafra D., Nrf2-keap1 system versus NF- B: the good and the evil in chronic kidney disease? Biochimie 2012 94 12 2461 2466
9. Ghosh S., Hayden M. S., New regulators of NF-kappaB in inflammation. Nature Reviews Immunology 2008 8 11 837 848
10. Nam J. S., Cho M. H., Lee G. T., Park J. S., Ahn C. W., Cha B. S., Lim S. K., Kim K. R., Ha H. J., Lee H. C., The activation of NF- B and AP-1 in peripheral blood mononuclear cells isolated from patients with diabetic nephropathy. Diabetes Research and Clinical Practice 2008 81 1 25 32 2-s2.0-44649166922 10.1016/j.diabres.2008.01.032
11. Mezzano S., Aros C., Droguett A., Burgos M. E., Ardiles L., Flores C., Schneider H., Ruiz-Ortega M., Egido J., NF- B activation and overexpression of regulated genes in human diabetic nephropathy. Nephrology Dialysis Transplantation 2004 19 10 2505 2512 2-s2.0-5444272878 10.1093/ndt/gfh207 (Pubitemid 39360096)
12. Chen L., Zhang J., Zhang Y., Wang Y., Wang B., Improvement of inflammatory responses associated with NF- B pathway in kidneys from diabetic rats. Inflammation Research 2008 57 5 199 204 2-s2.0-46449103466 10.1007/s00011-006-6190-z
13. Zheng H., Whitman S. A., Wu W., Wondrak G. T., Wong P. K., Fang D., Zhang D. D., Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes 2011 60 11 3055 3066
14. Vomhof-Dekrey E. E., Picklo M. J. Sr., The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism. The Journal of Nutritional Biochemistry 2012 23 10 1201 1206
15. Kim H. J., Vaziri N. D., Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. American Journal of Physiology 2010 298 3 F662 F671 2-s2.0-77649093421 10.1152/ajprenal.00421.2009
16. Jiang T., Huang Z., Lin Y., Zhang Z., Fang D., Zhang D. D., The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes 2010 59 4 850 860 2-s2.0-77951199503 10.2337/db09-1342
17. Kanwar Y. S., Wada J., Sun L., Xie P., Wallner E. I., Chen S., Chugh S., Danesh F. R., Diabetic nephropathy: mechanisms of renal disease progression. Experimental Biology and Medicine 2008 233 1 4 11 2-s2.0-37549035027 10.3181/0705-MR-134
18. Ayo S. H., Radnik R., Garoni J. A., Troyer D. A., Kreisberg J. I., High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell culture. American Journal of Physiology 1991 261 4, part 2 F571 F577 2-s2.0-0025990146
19. Sobhia M. E., Grewal B. K., Bhat J., Rohit S., Punia V., Protein kinase C β II in diabetic complications: survey of structural, biological and computational studies. Expert Opinion on Therapeutic Targets 2012 16 3 325 344
20. Morino K., Petersen K. F., Shulman G. I., Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 2006 55 2 S9 S15 2-s2.0-33845542745 10.2337/db06-S002 (Pubitemid 44927027)
21. Ikeda A., Matsushita S., Sakakibara Y., Inhibition of protein kinase C β ameliorates impaired angiogenesis in type I diabetic mice complicating myocardial infarction. Circulation Journal 2012 76 4 943 949
22. Meier M., Park J. K., Overheu D., Kirsch T., Lindschau C., Gueler F., Leitges M., Menne J., Haller H., Deletion of protein kinase C- β isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin- induced diabetic mouse model. Diabetes 2007 56 2 346 354 2-s2.0-33847056610 10.2337/db06-0891
23. Gencel V. B., Benjamin M. M., Bahou S. N., Khalil R. A., Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease. Mini-Reviews in Medicinal Chemistry 2012 12 2 149 174
24. Stephenson T. J., Setchell K. D. R., Kendall C. W. C., Jenkins D. J. A., Anderson J. W., Fanti P., Effect of soy protein-rich diet on renal function in young adults with insulin-dependent diabetes mellitus. Clinical Nephrology 2005 64 1 1 11 2-s2.0-22144493016 (Pubitemid 40975059)
25. Orgaard A., Jensen L., The effects of soy isoflavones on obesity. Experimental Biology and Medicine 2008 233 9 1066 1080
26. Pavese J. M., Farmer R. L., Bergan R. C., Inhibition of cancer cell invasion and metastasis by genistein. Cancer and Metastasis Reviews 2010 29 3 465 482 2-s2.0-77957578387 10.1007/s10555-010-9238-z
27. Palanisamy N., Viswanathan P., Anuradha C. V., Effect of genistein, a soy isof lavone, on whole body insulin sensitivity and renal damage induced by a high-fructose diet. Renal Failure 2008 30 6 645 654 2-s2.0-48149114518 10.1080/08860220802134532
28. Yuan W. J., Jia F. Y., Meng J. Z., Effects of genistein on secretion of extracellular matrix components and transforming growth factor beta in high-glucose-cultured rat mesangial cells. Journal of Artificial Organs 2009 12 4 242 246 2-s2.0-77949896132 10.1007/s10047-009-0479-y
29. Elmarakby A. A., Ibrahim A. S., Faulkner J., Mozaffari M. S., Liou G. I., Abdelsayed R., Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice. Vascular Pharmacology 2011 55 5-6 149 156
30. Levitan I., Volkov S., Subbaiah P. V., Oxidized LDL: diversity, patterns of recognition, and pathophysiology. Antioxidants and Redox Signaling 2010 13 1 39 75 2-s2.0-77952966112 10.1089/ars.2009.2733
31. Valsecchi A. E., Franchi S., Panerai A. E., Sacerdote P., Trovato A. E., Colleoni M., Genistein, a natural phytoestrogen from soy, relieves neuropathic pain following chronic constriction sciatic nerve injury in mice: Anti-inflammatory and antioxidant activity. Journal of Neurochemistry 2008 107 1 230 240 2-s2.0-51849101592 10.1111/j.1471-4159.2008.05614.x
32. Al-Shamaony L., Al-Khazraji S. M., Twaij H. A. A., Hypoglycaemic effect of Artemisia herba alba. II. Effect of a valuable extract on some blood parameters in diabetic animals. Journal of Ethnopharmacology 1994 43 3 167 171 2-s2.0-0028037942 10.1016/0378-8741(94)90038-8 (Pubitemid 24232182)
33. Andallu B., Varadacharyulu N. C., Antioxidant role of mulberry (Morus indica L. cv. Anantha) leaves in streptozotocin-diabetic rats. Clinica Chimica Acta 2003 338 1-2 3 10 2-s2.0-0344082211 10.1016/S0009-8981(03)00322-X (Pubitemid 37460992)
34. Pi-Sunyer F. X., Weight loss in type 2 diabetic patients. Diabetes Care 2005 28 6 1526 1527 2-s2.0-19944380155 10.2337/diacare.28.6.1526 (Pubitemid 40756731)
35. Choi M. S., Jung U. J., Yeo J., Kim M. J., Lee M. K., Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes/Metabolism Research and Reviews 2008 24 1 74 81 2-s2.0-38749085618 10.1002/dmrr.780 (Pubitemid 351176003)
36. Babu P. V., Si H., Fu Z., Zhen W., Liu D., Genistein prevents hyperglycemia-induced monocyte adhesion to human aortic endothelial cells through preservation of the cAMP signaling pathway and ameliorates vascular inflammation in obese diabetic mice. Journal of Nutrition 2012 142 4 724 730
37. Yamagishi S. I., Fukami K., Ueda S., Okuda S., Molecular mechanisms of diabetic nephropathy and its therapeutic intervention. Current Drug Targets 2007 8 8 952 959 2-s2.0-34548397224 10.2174/138945007781386884
38. Ventura-Sobrevilla J., Boone-Villa V. D., Aguilar C. N., Román-Ramos R., Vega-Avila E., Campos-Sepúlveda E., Alarcón-Aguilar F., Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice. Proceedings of the Western Pharmacology Society 2011 54 5 9
39. Matteucci E., Giampietro O., Proposal open for discussion: defining agreed diagnostic procedures in experimental diabetes research. Journal of Ethnopharmacology 2008 115 2 163 172 2-s2.0-37249048293 10.1016/j.jep.2007.08. 040 (Pubitemid 350266257)
40. Yang W., Wang S., Li L., Liang Z., Wang L., Genistein reduces hyperglycemia and islet cell loss in a high-dosage manner in rats with alloxan-induced pancreatic damage. Pancreas 2011 40 3 396 402 2-s2.0-79954426590 10.1097/MPA.0b013e318204e74d
41. Mooradian A. D., Dyslipidemia in type 2 diabetes mellitus. Nature Clinical Practice Endocrinology & Metabolism 2009 5 3 150 159
42. Cerasola G., Guarneri M., Cottone S., Inflammation, oxidative stress and kidney function in arterial hypertension. Giornale Italiano di Nefrologia 2009 26 8 13 2-s2.0-77953182949
43. Cottone S., Lorito M. C., Riccobene R., Nardi E., Mulè G., Buscemi S., Geraci C., Guarneri M., Arsena R., Cerasola G., Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. Journal of Nephrology 2008 21 2 175 179 2-s2.0-50049130554
44. Lee J. S., Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sciences 2006 79 16 1578 1584 2-s2.0-33748065969 10.1016/j.lfs.2006.06.030 (Pubitemid 44301276)
45. Fu Z., Gilbert E. R., Pfeiffer L., Zhang Y., Fu Y., Liu D., Genistein ameliorates hyperglycemia in a mouse model of nongenetic type 2 diabetes. Applied Physiology, Nutrition, and Metabolism 2012 37 3 480 488
46. Kadkhodaee M., Mikaeili S., Zahmatkesh M., Golab F., Seifi B., Arab H. A., Shams S., Mahdavi-Mazdeh M., Alteration of renal functional, oxidative stress and inflammatory indices following hepatic ischemia-reperfusion. General Physiology and Biophysics 2012 31 2 195 202
47. Sung M. J., Kim D. H., Jung Y. J., Kang K. P., Lee A. S., Lee S., Kim W., Davaatseren M., Hwang J. T., Kim H. J., Kim M. S., Kwon D. Y., Park S. K., Genistein protects the kidney from cisplatin-induced injury. Kidney International 2008 74 12 1538 1547 2-s2.0-57049139332 10.1038/ki.2008.409
48. Kang J., Pervaiz S., Mitochondria: redox metabolism and dysfunction. Biochemistry Research International 2012 2012 14 896751
49. Ozbek E., Induction of oxidative stress in kidney. International Journal of Nephrology 2012 2012 9 465897
50. Valko M., Leibfritz D., Moncol J., Cronin M. T. D., Mazur M., Telser J., Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry and Cell Biology 2007 39 1 44 84 2-s2.0-33749986298 10.1016/j.biocel.2006.07.001 (Pubitemid 44566469)
51. Valsecchi A. E., Franchi S., Panerai A. E., Rossi A., Sacerdote P., Colleoni M., The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model. European Journal of Pharmacology 2011 650 2-3 694 702 2-s2.0-78651064824 10.1016/j.ejphar.2010.10.060
52. Salvi M., Brunati A. M., Clari G., Toninello A., Interaction of genistein with the mitochondrial electron transport chain results in opening of the membrane transition pore. Biochimica et Biophysica Acta 2002 1556 2-3 187 196 2-s2.0-0037010863 10.1016/S0005-2728(02)00361-4 (Pubitemid 35379677)
53. Motohashi H., Yamamoto M., Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends in Molecular Medicine 2004 10 11 549 557 2-s2.0-7244253081 10.1016/j.molmed.2004.09.003 (Pubitemid 39433824)
54. Wang F., Tian F., Whitman S. A., Zhang D. D., Nishinaka T., Zhang N., Jiang T., Regulation of transforming growth factor beta1-dependent aldose reductase expression by the Nrf2 signal pathway in human mesangial cells. European Journal of Cell Biology 2012 91 10 774 781
55. Ungvari Z., Bailey-Downs L., Gautam T., Jimenez R., Losonczy G., Zhang C., Ballabh P., Recchia F. A., Wilkerson D. C., Sonntag W. E., Pearson K., de Cabo R., Csiszar A., Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. American Journal of Physiology 2011 300 4 H1133 H1140
56. Pi J., Zhang Q., Fu J., Woods C. G., Hou Y., Corkey B. E., Collins S., Andersen M. E., ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicology and Applied Pharmacology 2010 244 1 77 83 2-s2.0-77649275621 10.1016/j.taap.2009.05.025
57. Park C. H., Noh J. S., Kim J. H., Tanaka T., Zhao Q., Matsumoto K., Shibahara N., Yokozawa T., Evaluation of morroniside, iridoid glycoside from Corni Fructus, on diabetes-induced alterations such as oxidative stress, inflammation, and apoptosis in the liver of type 2 diabetic db/db mice. Biological & Pharmaceutical Bulletin 2011 34 10 1559 1565
58. Koya D., Hayashi K., Kitada M., Kashiwagi A., Kikkawa R., Haneda M., Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. Journal of the American Society of Nephrology 2003 14 3 S250 S253 2-s2.0-0042867404 (Pubitemid 36903935)
59. Sechi L. A., Ceriello A., Griffin C. A., Catena C., Amstad P., Schambelan M., Bartoli E., Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia 1997 40 1 23 29 2-s2.0-0031013176 10.1007/s001250050638 (Pubitemid 27035706)
60. Zhang T., Wang F., Xu H. X., Yi L., Qin Y., Chang H., Mi M. T., Zhang Q. Y., Activation of nuclear factor erythroid 2-related factor 2 and PPAR γ plays a role in the genistein-mediated attenuation of oxidative stress-induced endothelial cell injury. British Journal of Nutrition 2013 109 2 223 235
61. Abraham N. G., Kappas A., Pharmacological and clinical aspects of heme oxygenase. Pharmacological Reviews 2008 60 1 79 127 (Pubitemid 351439218)
62. Bao W., Song F., Li X., Rong S., Yang W., Zhang M., Yao P., Hao L., Yang N., Hu F. B., Liu L., Plasma heme oxygenase-1 concentration is elevated in individuals with type 2 diabetes mellitus. PLoS ONE 2010 5 8, article e12371 2-s2.0-77957882550 10.1371/journal.pone.0012371
63. Rodriguez F., Lopez B., Perez C., Fenoy F. J., Hernandez I., Stec D. E., Li Volti G., Salom M. G., Chronic tempol treatment attenuates the renal hemodynamic effects induced by a heme oxygenase inhibitor in streptozotocin diabetic rats. American Journal of Physiology 2011 301 5 R1540 R1548
64. Csonka C., Pataki T., Kovacs P., Müller S. L., Schroeter M. L., Tosaki A., Blasig I. E., Effects of oxidative stress on the expression of antioxidative defense enzymes in spontaneously hypertensive rat hearts. Free Radical Biology and Medicine 2000 29 7 612 619 2-s2.0-0033805227 10.1016/S0891-5849(00)00365-8
65. Judge S., Young M. J., Smith A., Hagen T., Leeuwenburgh C., Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB Journal 2005 19 3 419 421 2-s2.0-14644417749 10.1096/fj.04-2622fje (Pubitemid 40316536)
66. 2-induced oxidative stress on antioxidant enzyme activities. Free Radical Research 2009 43 4 340 347 2-s2.0-67649514051 10.1080/10715760902751894
67. Díaz-Flores M., Angeles-Mejia S., Baiza-Gutman L. A., Medina-Navarro R., Hernández-Saavedra D., Ortega-Camarillo C., Roman-Ramos R., Cruz M., Alarcon-Aguilar F. J., Effect of an aqueous extract of Cucurbita ficifolia Bouchéon the glutathione redox cycle in mice with STZ-induced diabetes. Journal of Ethnopharmacology 2012 144 1 101 108
68. Lau A., Villeneuve N. F., Sun Z., Wong P. K., Zhang D. D., Dual roles of Nrf2 in cancer. Pharmacological Research 2008 58 5-6 262 270 2-s2.0-56649083534 10.1016/j.phrs.2008.09.003
69. Schmid H., Boucherot A., Yasuda Y., Henger A., Brunner B., Eichinger F., Nitsche A., Kiss E., Bleich M., Gröne H. J., Nelson P. J., Schlöndorff D., Cohen C. D., Kretzler M., Modular activation of nuclear factor- B transcriptional programs in human diabetic nephropathy. Diabetes 2006 55 11 2993 3003 2-s2.0-33845526226 10.2337/db06-0477 (Pubitemid 44923635)
70. Kim J., Sohn E., Kim C. S., Jo K., Kim J. S., The role of high-mobility group box-1 protein in the development of diabetic nephropathy. American Journal of Nephrology 2011 33 6 524 529 2-s2.0-79956218866 10.1159/000327992
71. Palanisamy N., Kannappan S., Anuradha C. V., Genistein modulates NF- B-associated renal inflammation, fibrosis and podocyte abnormalities in fructose-fed rats. European Journal of Pharmacology 2011 667 1-3 355 364
72. Viatour P., Merville M. P., Bours V., Chariot A., Phosphorylation of NF- B and I B proteins: implications in cancer and inflammation. Trends in Biochemical Sciences 2005 30 1 43 52 2-s2.0-11844269840 10.1016/j.tibs.2004.11. 009 (Pubitemid 40093740)
73. Alves M., Calegari V. C., Cunha D. A., Saad M. J. A., Velloso L. A., Rocha E. M., Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats. Diabetologia 2005 48 12 2675 2681 2-s2.0-28444438546 10.1007/s00125-005-0010-9 (Pubitemid 41738237)
74. Navarro-González J. F., Jarque A., Muros M., Mora C., García J., Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy. Cytokine & Growth Factor Reviews 2009 20 2 165 173
75. Navarro J. F., Milena F. J., Mora C., León C., Claverie F., Flores C., García J., Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition. Kidney International 2005 99 S98 S102 2-s2.0-33644969623
76. Taslipinar A., Yaman H., Yilmaz M. I., Demirbas S., Saglam M., Taslipinar M. Y., Agilli M., Kurt Y. G., Sonmez A., Azal O., Bolu E., Yenicesu M., Kutlu M., The relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy. Scandinavian Journal of Clinical & Laboratory Investigation 2011 71 7 606 612
77. Liu F., Chen H. Y., Huang X. R., Chung A. C., Zhou L., Fu P., Szalai A. J., Lan H. Y., C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes. Diabetologia 2011 54 10 2713 2723
78. Czyzewska J., Wasilewska K., Kamińska J., Koper O., Kemona H., Jakubowska I., Assess the impact of concentrations of inflammatory markers IL-6, CRP in the presence of albuminuria in patients with type 2 diabetes. Polski Merkuriusz Lekarski 2012 32 188 98 102
79. Hall W. L., Vafeiadou K., Hallund J., Bügel S., Koebnick C., Reimann M., Ferrari M., Branca F., Talbot D., Dadd T., Nilsson M., Dahlman-Wright K., Gustafsson J., Minihane A. M., Williams C. M., Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. American Journal of Clinical Nutrition 2005 82 6 1260 1268 2-s2.0-33644693570 (Pubitemid 43779725)
80. Fanti P., Asmis R., Stephenson T. J., Sawaya B. P., Franke A. A., Positive effect of dietary soy in ESRD patients with systemic inflammation-correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrology Dialysis Transplantation 2006 21 8 2239 2246 2-s2.0-33748076106 10.1093/ndt/gfl169 (Pubitemid 44295051)
81. Kaur H., Chien A., Jialal I., Hyperglycemia induced toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy. American Journal of Physiology 2012 303 8 F1145 F1150
82. Gottstein N., Ewins B. A., Eccleston C., Hubbard G. P., Kavanagh I. C., Minihane A. M., Weinberg P. D., Rimbach G., Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function. British Journal of Nutrition 2003 89 5 607 615 2-s2.0-0037721599 10.1079/BJN2003820 (Pubitemid 36592088)
83. Surh Y. J., Chun K. S., Cha H. H., Han S. S., Keum Y. S., Park K. K., Lee S. S., Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF- B activation. Mutation Research 2001 480-481 243 268 2-s2.0-0035451363 (Pubitemid 32744832)
84. Li Y. S., Wu L. P., Li K. H., Liu Y. P., Xiang R., Zhang S. B., Zhu L. Y., Zhang L. Y., Involvement of nuclear factor B (NF- B) in the downregulation of cyclooxygenase-2 (COX-2) by genistein in gastric cancer cells. Journal of International Medical Research 2011 39 6 2141 2150
85. Way K. J., Katai N., King G. L., Protein kinase C and the development of diabetic vascular complications. Diabetic Medicine 2001 18 12 945 959 2-s2.0-0035669720 10.1046/j.0742-3071.2001.00638.x (Pubitemid 34042930)
86. Xia P., Aiello L. P., Ishii H., Jiang Z. Y., Park D. J., Robinson G. S., Takagi H., Newsome W. P., Jirousek M. R., King G. L., Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. Journal of Clinical Investigation 1996 98 9 2018 2026 2-s2.0-2642709170 (Pubitemid 26376289)
87. Kelly D. J., Zhang Y., Hepper C., Gow R. M., Jaworski K., Kemp B. E., Wilkinson-Berka J. L., Gilbert R. E., Protein kinase C β inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension. Diabetes 2003 52 2 512 518 2-s2.0-0037315791 10.2337/diabetes.52.2.512 (Pubitemid 36173211)
88. Malhotra A., Kang B. P. S., Cheung S., Opawumi D., Meggs L. G., Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin I. Diabetes 2001 50 8 1918 1926 2-s2.0-0035430525 (Pubitemid 33641614)
89. Palanisamy N., Venkataraman A. C., Beneficial effect of genistein on lowering blood pressure and kidney toxicity in fructose-fed hypertensive rats. British Journal of Nutrition. In press
90. Qi M. Y., Kai-Chen, Liu H. R., Su Y. H., Yu S. Q., Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β 1 and type IV collagen expression in rats. Journal of Ethnopharmacology 2011 138 3 731 736
91. Anjaneyulu M., Berent-Spillson A., Inoue T., Choi J., Cherian K., Russell J. W., Transforming growth factor- β induces cellular injury in experimental diabetic neuropathy. Experimental Neurology 2008 211 2 469 479 2-s2.0-43449113242 10.1016/j.expneurol.2008.02.011
92. Kim Y. S., Kim N. H., Jung D. H., Jang D. S., Lee Y. M., Kim J. M., Kim J. S., Genistein inhibits aldose reductase activity and high glucose-induced TGF- β 2 expression in human lens epithelial cells. European Journal of Pharmacology 2008 594 1-3 18 25 2-s2.0-50549095066 10.1016/j.ejphar.2008.07.033
93. Behloul N., Wu G., Genistein: a promising therapeutic agent for obesity and diabetes treatment. European Journal of Pharmacology 2013 698 1-3 31 38